Answers are grounded in this paper and cite their sources.
Accumulating evidence suggests that hepatitis E virus (HEV) infection is an emerging disease in regions where HEV is nonendemic. In France, the prevalence of anti-HEV antibodies in the general population has never been studied. Using blood donors' samples, we have found a prevalence of 3.20%, which is similar to that of other industrialized countries.
No takes yet. Share an insight, caveat, or question.
Boutrouille et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: